Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Canrib 150mg Tablet
Manufacturer/Marketed By : ADLEY FORMULATIONS
$137.77 $89.29
Canrib 150mg Tablet belongs to the class of cancer medications known as PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitors, containing the active ingredient Olaparib. It is used to treat pancreatic,...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
OLAPARIB
Active Pharmaceutical Ingredient
Canrib 150mg Tablet
137,77$
89,29$
Canrib 150mg Tablet belongs to the class of cancer medications known as PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitors, containing the active ingredient Olaparib. It is used to treat pancreatic, and prostate cancer. This medication can be given alone or in combination with other anticancer medications. It is not recommended to take olaparib if you are allergic to the active compound and other ingredients of the medicine. Speak with your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood tests before and every month during the treatment, as this medicine could reduce the counts of RBC, WBC, and platelets. Tell your healthcare provider before starting treatment, if you have been diagnosed with problems in your lungs, liver, heart, or kidneys. It is not advised to use this medication while pregnant since it may harm the fetus and cause miscarriage. Therefore, for women of reproductive age, it is recommended to get a pregnancy test before beginning this medication. It is preferable to keep using birth control for at least six months after treatment is finished. While receiving treatment, it is not advised to breastfeed your child because it is unknown if Canrib 150mg Tablet will find its way into the breast milk. Men are not advised to donate sperm for at least 3 months after the treatment is finished. It is necessary to inform your doctor about all the medicines you are taking including prescription, over the counter drugs, vitamins and supplements.
Active Pharmaceutical Ingredient
Uses
• Treatment of Prostate cancer
• Metastatic Pancreatic cancer
Benefits
Canrib 150mg Tablet works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells. By inhibiting PARP, Canrib 150mg Tablet prevents cancer cells from repairing their DNA, leading to cell death. This targeted approach is especially effective in cancers with defective DNA repair mechanisms.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Most Common Side Effects
• Shortness of breath
• Nausea
• Vomiting
• Fatigue
• Dyspepsia
• Loss of appetite
• Dizziness
• Diarrhoea
• Headache
Common Side Effects
• Neutropenia
• Acute myeloid leukemia
• Leukopenia
• Thrombocytopenia
• Lung problems
How To Use
The medicine will be prescribed to you by a healthcare professional in a hospital setting. Canrib 150mg Tablet is available as a tablet to be taken with or without food, as directed by your healthcare provider. The dose will be decided by your healthcare professional based on your conditions. Avoid crushing, opening, or dissolving the tablet and swallow it whole with a glass of water. Take the Canrib 150mg Tablet at the same time every day.
Safety Advice
• Breast Feeding: It is unknown whether Canrib 150mg Tablet passes into the breast milk. It is not recommended to nurse a child during and after 1 month of completion of therapy. Please consult your doctor before breastfeeding.
• Alcohol: It is unknown whether consuming alcohol interacts with the Canrib 150mg Tablet. Please consult your doctor for more advice.
• Liver: It is unknown whether Canrib 150mg Tablet is safe in individuals with liver disorders. Inform your physician if you have any liver problems before starting the treatment.
• Lungs: Consult your doctor if you have any lung diseases before starting the treatment with Canrib 150mg Tablet.
• Driving: Canrib 150mg Tablet may have an impact on your ability to operate machinery and drive. It is not recommended to operate machinery or drive vehicles if you experience lightheadedness, weakness, or exhaustion.
• Pregnancy: It is not recommended to take Canrib 150mg Tablet during pregnancy as it may harm your unborn baby. It is necessary to inform your doctor if you are pregnant or planning to become pregnant.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.